Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $106B |
| FY2017, ended Dec 30, 2017 | $94.8B |
| FY2018, ended Dec 29, 2018 | $53.2B |
| FY2019, ended Dec 28, 2019 | $38.6B |
| FY2020, ended Dec 26, 2020 | $42.8B |
| FY2021, ended Dec 25, 2021 | $43.1B |
| FY2022, ended Dec 31, 2022 | $49.9B |
| FY2023, ended Dec 30, 2023 | $44.9B |
| FY2024, ended Dec 28, 2024 | $36.7B |
| FY2025, ended Dec 27, 2025 | $28.6B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $28.1B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $26.5B |
| FY2017, ended Dec 30, 2017 | $26.2B |
| FY2018, ended Dec 29, 2018 | $26.3B |
| FY2019, ended Dec 28, 2019 | $25.0B |
| FY2020, ended Dec 26, 2020 | $26.2B |
| FY2021, ended Dec 25, 2021 | $26.0B |
| FY2022, ended Dec 31, 2022 | $26.5B |
| FY2023, ended Dec 30, 2023 | $26.6B |
| FY2024, ended Dec 28, 2024 | $25.8B |
| FY2025, ended Dec 27, 2025 | $24.9B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $24.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.60B | $1.40B |
| FY2017, ended Dec 30, 2017 | $10.9B | −$693M |
| FY2018, ended Dec 29, 2018 | −$10.2B | $1.75B |
| FY2019, ended Dec 28, 2019 | $1.94B | $2.78B |
| FY2020, ended Dec 26, 2020 | $356M | $4.33B |
| FY2021, ended Dec 25, 2021 | $1.01B | $4.46B |
| FY2022, ended Dec 31, 2022 | $2.36B | $1.55B |
| FY2023, ended Dec 30, 2023 | $2.85B | $2.96B |
| FY2024, ended Dec 28, 2024 | $2.74B | $3.16B |
| FY2025, ended Dec 27, 2025 | −$5.85B | $3.66B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | −$3.40B | $3.82B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.20B |
| FY2017, ended Dec 30, 2017 | $1.63B |
| FY2018, ended Dec 29, 2018 | $1.13B |
| FY2019, ended Dec 28, 2019 | $2.28B |
| FY2020, ended Dec 26, 2020 | $3.42B |
| FY2021, ended Dec 25, 2021 | $3.44B |
| FY2022, ended Dec 31, 2022 | $1.04B |
| FY2023, ended Dec 30, 2023 | $1.40B |
| FY2024, ended Dec 28, 2024 | $1.33B |
| FY2025, ended Dec 27, 2025 | $2.62B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $2.42B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $32.4B |
| FY2017, ended Dec 30, 2017 | $31.5B |
| FY2018, ended Dec 29, 2018 | $31.2B |
| FY2019, ended Dec 28, 2019 | $29.2B |
| FY2020, ended Dec 26, 2020 | $28.3B |
| FY2021, ended Dec 25, 2021 | $21.8B |
| FY2022, ended Dec 31, 2022 | $20.1B |
| FY2023, ended Dec 30, 2023 | $20.0B |
| FY2024, ended Dec 28, 2024 | $19.9B |
| FY2025, ended Dec 27, 2025 | $21.2B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $19.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 2.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.22B |
| FY2017, ended Dec 30, 2017 | 1.22B |
| FY2018, ended Dec 29, 2018 | 1.22B |
| FY2019, ended Dec 28, 2019 | 1.22B |
| FY2020, ended Dec 26, 2020 | 1.22B |
| FY2021, ended Dec 25, 2021 | 1.22B |
| FY2022, ended Dec 31, 2022 | 1.23B |
| FY2023, ended Dec 30, 2023 | 1.21B |
| FY2024, ended Dec 28, 2024 | 1.19B |
| FY2025, ended Dec 27, 2025 | 1.18B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | 1.19B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $46.0M |
| FY2017, ended Dec 30, 2017 | — | $46.0M |
| FY2018, ended Dec 29, 2018 | — | $33.0M |
| FY2019, ended Dec 28, 2019 | — | $46.0M |
| FY2020, ended Dec 26, 2020 | — | $156M |
| FY2021, ended Dec 25, 2021 | $271M | $197M |
| FY2022, ended Dec 31, 2022 | $280M | $148M |
| FY2023, ended Dec 30, 2023 | $455M | $141M |
| FY2024, ended Dec 28, 2024 | $988M | $109M |
| FY2025, ended Dec 27, 2025 | $436M | $95.0M |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $28.0M | $95.0M |
Valuation
At current price- Market Cap
- $28.5B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.1×
- Price / Book
- 0.8×
- EV / EBITDA
- n/m. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $24.9B
- Revenue Growth YoY
- −1.6%
- Revenue CAGR 3Y
- −2.0%
- Revenue CAGR 5Y
- −1.0%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 33.4%
- Operating Margin
- −12.8%
- Net Margin
- −13.6%
- FCF Margin
- 15.3%
- Return on Equity
- −8.8%
Earnings
Trailing 12 months- Net Income
- −$3.40B
- EPS (diluted)
- −$2.88
- EBITDA
- −$2.17B
- Operating Income
- −$3.18B
Balance Sheet
As of Jun 27, 2026- Cash and cash equivalents
- $2.42B
- Total Debt
- $19.0B
- Net Debt
- $16.6B
- Total Assets
- $73.1B
- Total Liabilities
- $36.9B
- Shareholders' Equity
- $36.0B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.62B
- Capital Expenditure
- $805M
- Free Cash Flow
- $3.82B
Dividends and risk
Last 12 months- Dividend Yield
- 6.7%
- Dividend / Share
- $1.60
- Beta (5Y)
- 0.12
Every ratio is calculated from the company’s reported figures.